{"version":"1.0","provider_name":"The Catapult Network","provider_url":"https:\/\/catapult.org.uk","author_name":"india campbell","author_url":"https:\/\/catapult.org.uk\/author\/india-campbellcatapultnetwork-org-uk\/","title":"Growing new capabilities with German company Rentschler Biopharma SE - The Catapult Network","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"De0Ipo4yd1\"><a href=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/growing-new-capabilities-with-german-company-rentschler-biopharma-se\/\">Growing new capabilities with German company Rentschler Biopharma SE<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/growing-new-capabilities-with-german-company-rentschler-biopharma-se\/embed\/#?secret=De0Ipo4yd1\" width=\"600\" height=\"338\" title=\"&#8220;Growing new capabilities with German company Rentschler Biopharma SE&#8221; &#8212; The Catapult Network\" data-secret=\"De0Ipo4yd1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2021\/12\/Rentschler_Arch_052-56k_Nukleus-CGTC.jpg","thumbnail_width":2000,"thumbnail_height":1389,"description":"Cell and Gene Therapy Catapult partnered with German based Rentschler Biopharma to enable the establishment of new ATMP development and manufacturing capabilities in the UK, to benefit the UK and international demand and further strengthen the UK ecosystem and international supply chain."}